| |
|
|
|
Corbus Pharmaceuticals Holdings Inc.  
|
|
7.52 0.25 (0.03%) |
10-17 16:00 |
|
Open: |
7.22 |
Pre close: |
7.27 |
Target:
|
10.01
|
|
High: |
7.61 |
Low: |
6.87 |
Resistance:
|
8.57
10.01
|
|
Volume: |
1,560,578 |
Market Cap: |
430M |
Support:
|
6.24
4.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.00
 |
MACD |
MACD(12,26):
|
0.32 |
|
MA(20): |
7.15 |
Signal(12,26,9): |
0.36  |
|
MA(100): |
5.72 |
Stochastic Oscillator |
%K(14,3):
|
37.11 |
|
MA(250): |
6.50 |
%D(3): |
25.22 |
|
Average Volume(K) |
3-Month: |
128715
|
52-Week |
High:
|
9.95 |
|
10-Days: |
123304 |
Low: |
4.50 |
|
RSI |
RSI(14):
|
61.24 |
Change(%): |
-2.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.760 |
Return on Equity (ttm) |
-88.2 |
Shares Out. (M) |
57.21 |
|
EPS Est. Current Year |
-0.640 |
Return on Assets (ttm) |
-71.5 |
Shares Float (M) |
57.21 |
|
EPS Est. Next Year |
-0.680 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
143.8 |
% Held by Institutions |
44.60 |
|
Forward EPS |
-1.060 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
13305 |
|
Book Value (p.s.) |
6.760 |
EBITDA (p.s.) |
-0.119 |
P/E |
-9.89 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.60 |
P/S |
8604384256.00 |
|
Operating Margin |
-1618.11 |
Levered Free Cash Flow
(M) |
-17.36 |
P/CF |
-19.03 |
|
|
|
|
|
|
